Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Virginie Gourdou‐Latyszenok"'
Autor:
Maria Y. Najem, Ryan N. Rys, Sandrine Laurance, François‐René Bertin, Virginie Gourdou‐Latyszenok, Lénaïck Gourhant, Lauriane Le Gall, Rozenn Le Corre, Francis Couturaud, Mark D. Blostein, Catherine A. Lemarié
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background Venous thromboembolism is associated with endothelial cell activation that contributes to the inflammation‐dependent activation of the coagulation system. Cellular damage is associated with the release of different species of extracellul
Externí odkaz:
https://doaj.org/article/67f57dfc8de74c6982911de9874d5841
Autor:
Marion Pilard, Estelle L. Ollivier, Virginie Gourdou-Latyszenok, Francis Couturaud, Catherine A. Lemarié
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Reduced blood flow velocity in the vein triggers inflammation and is associated with the release into the extracellular space of alarmins or damage-associated molecular patterns (DAMPs). These molecules include extracellular nucleic acids, extracellu
Externí odkaz:
https://doaj.org/article/6f92a0aee8124cac92f509d0d9b22cc1
Autor:
Alexandre Guy, Virginie Gourdou-Latyszenok, Nicolas Le Lay, Claire Peghaire, Badr Kilani, Juliana Vieira Dias, Cécile Duplaa, Marie-Ange Renault, Cécile Denis, Jean Luc Villeval, Yacine Boulaftali, Martine Jandrot-Perrus, Thierry Couffinhal, Chloe James
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Thrombosis is the main cause of morbidity and mortality in patients with JAK2V617F myeloproliferative neoplasms. Recent studies have reported the presence of JAK2V617F in endothelial cells of some patients with myeloproliferative neoplasms. We invest
Externí odkaz:
https://doaj.org/article/2fa70e2d604a4b19b50aa6fedb21a695
Autor:
Alexandre Guy, Virginie Gourdou-Latyszenok, Sylvie Labrouche-Colomer, Laure Deloison, Marie-Ange Renault, Etienne Rivière, Chloé James, Simon Favre
Publikováno v:
Leukemia. 33(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028a5f0a175e2274d1f45d9336b97749
https://pubmed.ncbi.nlm.nih.gov/31175322
https://pubmed.ncbi.nlm.nih.gov/31175322
Autor:
Thierry Couffinhal, Claire Peghaire, Badr Kilani, Marie Parrens, Marie-Ange Renault, Marie-Lise Bats, Chloé James, Alexandre Guy, Virginie Gourdou-Latyszenok, Jean-Luc Villeval, Pierre-Emmanuel Rautou, Cécile Duplàa
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2019, 17 (5), pp.827-840. ⟨10.1111/jth.14417⟩
Journal of Thrombosis and Haemostasis, Wiley, 2019, 17 (5), pp.827-840. ⟨10.1111/jth.14417⟩
Essentials To reliably study the respective roles of blood and endothelial cells in hemostasis, mouse models with a strong and specific endothelial expression of the Cre recombinase are needed. Using mT/mG reporter mice and conditional JAK2V617F/WT m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a097f678dd6674d18431fcdfad28f71c
http://hdl.handle.net/20.500.12278/26920
http://hdl.handle.net/20.500.12278/26920
Autor:
Badr Kilani, Olivier Mansier, Caroline Marty, Amelie V. Guitart, Alexandre Guy, Virginie Gourdou-Latyszenok, Marie Parrens, Isabelle Plo, William Vainchenker, Chloé James
Publikováno v:
Blood
Blood, American Society of Hematology, 2019, 134 (26), pp.2383-2387. ⟨10.1182/blood.2019001163⟩
Blood, American Society of Hematology, 2019, 134 (26), pp.2383-2387. ⟨10.1182/blood.2019001163⟩
The major weakness of most knock-in JAK2V617F mouse models is the presence of the JAK2 mutation in all rather than in a few hematopoietic stem cells (HSC), such as in human "early-stage" myeloproliferative neoplasms (MPN). Understanding the mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3309b40fa86ef8912618a82c2a9ab7
https://hal.archives-ouvertes.fr/hal-03194452
https://hal.archives-ouvertes.fr/hal-03194452
Publikováno v:
JMV-Journal de Médecine Vasculaire. 44:135-136
Introduction La thrombose est la complication la plus frequente des neoplasies myeloproliferatives (NMP) BCR-ABL negatives mais sa physiopathologie reste encore floue. Parmi les facteurs de risque, l’âge superieur a 60 ans et l’antecedent de thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fc46b6007ae017bfbefb94d13f0b57f
https://doi.org/10.1016/j.jdmv.2018.12.101
https://doi.org/10.1016/j.jdmv.2018.12.101
Autor:
Raj Sewduth, Thierry Couffinhal, Cécile Duplàa, Virginie Gourdou-Latyszenok, Jean-Luc Villeval, Juliana Vieira Dias, Badr Kilani, Eric Lippert, Chloé James
Publikováno v:
Blood. 124:102-102
Background: Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders, characterized by significant increase in one or more myeloid lineages. A mutation in the Janus kinase 2 (JAK2) gene, JAK2V617F, was identified in half of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9839d5aa90f31a26eee15ad1f21b62ad
https://doi.org/10.1182/blood.v124.21.102.102
https://doi.org/10.1182/blood.v124.21.102.102